North American Neuromodulation Market to Grow at a CAGR of 9.6% to reach US$ 182.71 million from 2020 to 2027

North America Typhoid Fever Vaccines Market Forecast to 2027 - Covid-19 Impact and Regional Analysis by Vaccine Type (Live Attenuated Vaccine, Capsular Polysaccharide Vaccines, Conjugate Vaccine and Others) and Route of administration (Oral and Injectable) and Country

Publication Month: Nov 2020 | Report Code: TIPRE00016291 | No. of Pages: 86 | Category: Pharmaceuticals | Status: Published
Covid

The North America typhoid fever vaccines  market is expected to reach US$ 182.71 million in 2027 from US$ 89.84 million in 2019. The market is estimated to grow with a CAGR of 9.6% from 2020-2027.

The growth of the market is driven by the factors such as, increase in number of Americans travelling to developing countries. However, risks associated with typhoid fever vaccines  likely to have negative impact on the growth of the North America Typhoid Fever Vaccines market in the coming years.

 

Typhoid vaccination is not recommended on a routine basis; however, it is recommended for people traveling to places where typhoid fever is common.  Therefore, an increase in the number of Americans traveling outside the North American region is likely to favor the growth of the market.  As per the U.S. Commerce Department’s National Travel and Tourism Office, the number of U.S. citizens traveling outside the country for business and tourism increased by 6% in 2019, reaching a total of 93 million.

Furthermore, typhoid is more prevalent in Asian countries; as per the data by National Travel & Tourism Office, in 2019, around 7,886 thousand people traveled to Asia for business and leisure, which is a 5% increase than in 2018. Thus, an increasing number of US travelers to Asian countries is likely to demand typhoid vaccination.

 

Furthermore, North America is witnessing the growing number of COVID-19 cases, for instance, in the United States the number of cases has been increased to 1,895,507 with 108,79 deaths reported. Additionally, Mexico and Canada cases are also growing. Due to coronavirus spreading, many cities are shutting down causing treatments and doctor’s appointment cancellation. Supply chain disruptions associated with this pandemic situation will ultimately affect the sales of products for short period. Also, stay-at-home and shelter-in-place orders have resulted in decreased outpatient pediatric visits and fewer vaccine doses were administered, leaving children at risk for vaccine-preventable diseases. Therefore, it is likely to affect typhoid fever vaccines s market owing to above mention points.

 

Mexico Typhoid Fever Vaccines Market Revenue and Forecast to 2027 (US$ Mn)

Mexico Typhoid Fever Vaccines Market Revenue and Forecast to 2027 (US$ Mn)

Get more information on this report :


 

North America Typhoid Fever Vaccines  – Market Segmentation

 

By Vaccine Type

  • Live Attenuated Vaccine
  • Capsular Polysaccharide Vaccines
  • Conjugate Vaccine
  • Others

By Route of Administration

  • Oral
  • Injectable

By Country

  • US
  • Canada
  • Mexico

Company Profiles

  • Sanofi
  • GlaxoSmithKline plc
  • Paxvax Inc
  • Prokarium Ltd
  • Scandinavian Biopharma

1.          Introduction

1.1        Scope of the Study

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1        North America Typhoid Fever Vaccines Market – By Vaccine Type

1.3.2        North America Typhoid Fever Vaccines Market – By Route of Administration

1.3.3        North America Typhoid Fever Vaccines Market – By Country

2.          North America Typhoid Fever Vaccines Market – Key Takeaways

3.          Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.          North America Typhoid Fever Vaccines Market Landscape

4.1        Overview

4.2        PEST Analysis

4.2.1        North America Typhoid Fever Vaccines Market - North America PEST Analysis

4.3        Expert Opinion

5.          North America Typhoid Fever Vaccines Market Key Market Dynamics

5.1        Key Market Drivers

5.1.1        Increase in Number of Americans Travelling Outside North America

5.2        Key Restraints

5.2.1        Risks Associated with Typhoid Fever Vaccines

5.3        Key Market Opportunities

5.3.1        Increasing Pharmaceutical and Biopharmaceutical Industry

5.4        Future Trend

5.4.1        Initiatives to Reduce Typhoid Burden

5.5        Impact Analysis

6.          Typhoid Fever Vaccines Market – North America Analysis

6.1        North America Typhoid Fever Vaccines Market Revenue Forecasts and Analysis

7.          Typhoid Fever Vaccines Market – By Vaccine Type

7.1        Overview

7.2        Typhoid Fever Vaccines Market, by Vaccine Type, 2019 and 2027 (%)

7.3        Live Attenuated Vaccine

7.3.1        Overview

7.3.2        Live Attenuated Vaccine: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

7.5        Capsular Polysaccharide Vaccines

7.5.1        Overview

7.5.2        Capsular Polysaccharide Vaccines: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

7.6        Conjugate Vaccine

7.6.1        Overview

7.6.2        Conjugate Vaccine: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

7.7        Others

7.7.1        Overview

7.7.2        Others: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

8.          Typhoid Fever Vaccines Market Analysis – By Route of Administration

8.1        Overview

8.2        Typhoid Fever Vaccines Market Revenue Share, by Route of Administration (2019 and 2027)

8.2.1        Oral

8.2.1.1          Overview

8.2.2        Oral: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

8.3        Injectable

8.3.1        Overview

8.3.2        Injectable: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

9.          Typhoid Fever Vaccines Market Revenue and Forecasts To 2027 – Geographical Analysis

9.1        North America: Typhoid Fever Vaccines Market

9.1.1        Overview

9.1.2        North America: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.3        North America: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.1.4        North America: Typhoid Fever Vaccines Market, by Route of Administration, 2018–2027 (USD Million)

9.1.5        North America: Typhoid Fever Vaccines Market, by Country, 2019 & 2027 (%)

9.1.6        US: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.1          US: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.2          US: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.1.6.3          US: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)

9.1.7        Canada: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.1          Canada: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.2          Canada: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.1.7.3          Canada: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)

9.1.8        Mexico: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.1          Mexico: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.2          Mexico: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.1.8.3          Mexico: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)

10.       Impact of COVID-19 Pandemic on Global Typhoid Fever Vaccines Market

10.1      North America: Impact Assessment of COVID-19 Pandemic

11.       Company Profiles

11.1      Paxvax Inc.

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2      PT Bio Farma

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3      BIO-MED

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      Sanofi

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5      GlaxoSmithKline plc.

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

12.       Appendix

12.1      About The Insight Partners

12.2      Glossary of Terms

LIST OF TABLES

Table 1.            North America Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)

Table 2.            North America Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 3.            US Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)

Table 4.            US Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 5.            Canada Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)

Table 6.            Canada Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 7.            Mexico Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)

Table 8.            Mexico Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 9.            Glossary of Terms, North America Typhoid Fever Vaccines Market

LIST OF FIGURES

Figure 1.           Typhoid Fever Vaccines Market Segmentation

Figure 2.           North America Typhoid Fever Vaccines Market Overview

Figure 3.           Convex Segment Held Largest Share of Typhoid Fever Vaccines Market

Figure 4.           US Is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           North America Typhoid Fever Vaccines Market- Leading Country Markets (US$ Mn)

Figure 7.           North America : PEST Analysis

Figure 8.           Typhoid Fever Vaccines Market Impact Analysis of Drivers and Restraints

Figure 9.           North America Typhoid Fever Vaccines Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 10.        Typhoid Fever Vaccines Market, by Vaccine Type, 2019 and 2027 (%)

Figure 11.        Live Attenuated Vaccine: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 12.        Capsular Polysaccharide Vaccines: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 13.        Conjugate Vaccine: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 14.        Others: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 15.        Typhoid Fever Vaccines Market Revenue Share, by Route of Administration (2019 and 2027)

Figure 16.        Oral: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 17.        Injectable: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 18.        North America: Typhoid Fever Vaccines Market, by Key Country – Revenue (2019) (USD Million)

Figure 19.        North America Typhoid Fever Vaccines Market Revenue and Forecast to 2027 (USD Million)

Figure 20.        North America: Typhoid Fever Vaccines Market, by Country, 2019 & 2027 (%)

Figure 21.        US: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 22.        Canada: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 23.        Mexico: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 24.        Impact of COVID-19 Pandemic on Typhoid Fever Vaccines market in North American Countries

  1. Sanofi
  2. GlaxoSmithKline plc
  3. Paxvax Inc
  4. Prokarium Ltd
  5. Scandinavian Biopharma
  • To understand the North America typhoid fever vaccines  market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for North America typhoid fever vaccines  market
  • Efficiently plan M&A and partnership deals in North America typhoid fever vaccines  market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form North America typhoid fever vaccines  market
  • Obtain market revenue forecast for market by various segments from 2019-2027 in North America.
TIPRE00016291
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing